Mouse models for ATR deficiency

DNA Repair

Volumn 8, Issue 11, 2009, Pages 1333-1337

  O'Driscoll, Mark ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Ageing; ATM; ATR; Intrauterine programming; Replicative stress; Seckel syndrome; Stem cell attrition; Tissue homeostasis

Indexed keywords

ATM PROTEIN; ATR PROTEIN;

ARTICLE; DNA DAMAGE; DNA REPAIR; GENE MUTATION; GENE TARGETING; GENOMIC INSTABILITY; KNOCKOUT MOUSE; NEOPLASM; NONHUMAN; PREMATURE AGING; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; SECKEL SYNDROME;

ANIMALS; CELL CYCLE PROTEINS; DISEASE MODELS, ANIMAL; DNA DAMAGE; GENOMIC INSTABILITY; HUMANS; MICE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES;

EID: 70349852751     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2009.09.001     Document Type: Article

References (45)

1. Jazayeri A., Falck J., Lukas C., Bartek J., Smith G.C.M., Lukas J., and Jackson S.P. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat. Cell. Biol. 8 (2006) 37-45
2. Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., Shiloh Y., Crawley J.N., Ried T., Tagle D., and Wynshaw-Boris A. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86 (1996) 159-171
3. Barlow C., Liyanage M., Moens P.B., Tarsounas M., Nagashima K., Brown K., Rottinghaus S., Jackson S.P., Tagle D., Ried T., and Wynshaw-Boris A. Atm deficiency results in severe meiotic disruption as early as leptonema of prophase I. Development 125 (1998) 4007-4017
4. Herzog K.-H., Chong M.J., Kapsetaki M., Morgan J.I., and McKinnon P.J. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 280 (1998) 1089-1091
5. Xu Y., Ashley T., Brainerd E.E., Bronson R.T., Meyn M.S., and Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects and thymic lymphoma. Genes Dev. 10 (1996) 2411-2422
6. Westphal C.H., Rowan S., Schmaltz C., Elson A., Fisher D.E., and Leder P. atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat. Genet. 16 (1997) 397-401
7. de Klein A., Muijtjens M., van Os R., Verhoeven Y., Smit B., Carr A.M., Lehmann A.R., and Hoeijmakers J.H.J. Targeted disruption of the cell cycle checkpoint gene ATR leads to early embryonic lethality in mice. Curr. Biol. 10 (2000) 479-482
8. Brown E.J., and Baltimore D. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev. 14 (2000) 397-402
9. Lavin M.F. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell. Biol. 9 (2008) 759-769
10. Kerzendorfer C., and O'Driscoll M. Human DNA damage response and repair deficiency syndromes: linking genomic instability and cell cycle checkpoint proficiency. DNA Rep. 8 9 (2009) 1139-1152
11. Ruzankina Y., Pinzon-Guzman C., Asare A., Ong T., Pontano L., Cotsarelis G., Zediak V.P., Velez M., Bhandoola A., and Brown E.J. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell 1 (2007) 113-126
12. Ruzankina Y., Asare A., and Brown E.J. Replicative stress, stem cells and aging. Mech. Ageing Dev. 129 (2008) 460-466
13. Murga M., Bunting S., Montana M.F., Soria R., Mulero F., Canamero M., Lee Y., McKinnon P.J., Nussenzweig A., and Fernandez-Capetillo O. A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging. Nat. Genet. (2009) (advance online publication)
14. O'Driscoll M., Ruiz-Perez V.L., Woods C.G., Jeggo P.A., and Goodship J.A. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat. Genet. 33 (2003) 497-501
15. O'Driscoll M., and Jeggo P.A. Clinical impact of ATR checkpoint signalling failure in humans. Cell Cycle 2 (2003) 194-195
16. Ragland R., Arlt M., Hughes E., Saunders T., and Glover T. Mice hypomorphic for Atr have increased DNA damage and abnormal checkpoint response. Mamm. Genome 20 (2009) 375-385
17. Fowden A.L., Giussani D.A., and Forhead A.J. Intrauterine programming of physiological systems: causes and consequences. Physiology 21 (2006) 29-37
18. Fowden A.L., Forhead A.J., Coan P.M., and Burton G.J. The placenta and intrauterine programming. J. Neuroendocrinol. 20 (2008) 439-450
19. Barnes D.E., Stamp G., Rosewell I., Denzel A., and Lindahl T. Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice. Curr. Biol. 8 (1998) 1395-1398
20. Lee Y., Barnes D.E., Lindahl T., and McKinnon P.J. Defective neurogenesis resulting from DNA ligase IV deficiency requires Atm. Genes Dev. 14 (2000) 2576-2580
21. Goodship J., Gill H., Carter J., Jackson A., Splitt M., and Wright M. Autozygosity mapping of a seckel syndrome locus to chromosome 3q22. 1-q24. Am. J. Hum. Genet. 67 (2000) 498-503
22. Miller J., Turan S., and Baschat A.A. Fetal growth restriction. Semin. Perinatol. 32 (2008) 274-280
23. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald III E.R., Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., and Elledge S.J. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316 (2007) 1160-1166
24. Shima H.P., Pende M., Chen Y., Fumagalli S., Thomas G., and Kozma S.C. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J. 17 (1998) 6649-6659
25. Judith G., Hall C., Flora Jr. C.I.S., Pauli R.M., and Tanaka K.I. Majewski osteodysplastic primordial dwarfism type II (MOPD II): Natural history and clinical findings. Am. J. Med. Genet. 130A (2004) 55-72
26. Ducos B., Cabrol S., Houang M., Perin L., Holzenberger M., and Le Bouc Y. IGF Type 1 receptor ligand binding characteristics are altered in a subgroup of children with intrauterine growth retardation. J. Clin. Endocrinol. Metab. 86 (2001) 5516-5524
27. O'Driscoll M., and Jeggo P.A. The role of the DNA damage response pathways in brain development and microcephaly: insight from human disorders. DNA Rep. 7 (2008) 1039-1050
28. van der Pluijm I., Garinis G.A., Brandt R.M.C., Gorgels T.G.M.F., Wijnhoven S.W., Diderich K.E.M., de Wit J., Mitchell J.R., van Oostrom C., Beems R., Niedernhofer L.J., Velasco S., Friedberg E.C., Tanaka K., van Steeg H., Hoeijmakers J.H.J., and van der Horst G.T.J. Impaired genome maintenance suppresses the growth hormoneâ€"Insulin-like growth factor 1 axis in mice with cockayne syndrome. PLoS Biol. 5 (2006) e2
29. Niedernhofer L.J., Garinis G.A., Raams A., Lalai A.S., Robinson A.R., Appeldoorn E., Odijk H., Oostendorp R., Ahmad A., van Leeuwen W., Theil A.F., Vermeulen W., van der Horst G.T.J., Meinecke P., Kleijer W.J., Vijg J., Jaspers N.G.J., and Hoeijmakers J.H.J. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 444 (2006) 1038-1043
30. Monnat Jr. R.J. From broken to old: DNA damage, IGF1 endocrine suppression and aging. DNA Rep. 6 (2007) 1386-1390
31. Garinis G.A., Uittenboogaard L.M., Stachelscheid H., Fousteri M., van Ijcken W., Breit T.M., van Steeg H., Mullenders L.H.F., van der Horst G.T.J., Bruning J.C., Niessen C.M., Hoeijmakers J.H.J., and Schumacher B. Persistent transcription-blocking DNA lesions trigger somatic growth attenuation associated with longevity. Nat. Cell. Biol. 11 (2009) 604-615
32. Rodier F., Campisi J., and Bhaumik D. Two faces of p53: aging and tumor suppression. Nucleic Acids Res. 35 (2007) 7475-7484
33. Durkin S.G., and Glover T.W. Chromosome fragile sites. Annu. Rev. Genet. 41 (2007) 169-192
34. Fang Y., Tsao, Cheng-Chung, Goodman, Barbara K., Furumai, Ryohei, Tirado, Carlos A., Abraham, Robert T., and Wang X.-Fan. ATR functions as a gene dosage-dependent tumor suppressor on a mismatch repair-deficient background. EMBO J. 23 (2004) 3164-3174
35. Dierov J., Dierova R., and Carroll M. BCR/ABL translocates to the nucleus and disrupts an ATR-dependent intra-S phase checkpoint. Cancer Cell 5 (2004) 275-285
36. Liu A., Takakuwa, Tetsuya, Fujita, Shigeki, Ham, Maria Francisca, Luo, Wen-Juan, Daibata, Masanori, Aozasa, and Katsuyuki. Alterations of DNA damage-response genes ATM and ATR in pyothorax-associated lymphoma. Lab. Invest. 85 (2005) 436-446
37. Lewis K.A., Mullany, Sally, Thomas, Bijoy, Chien, Jeremy, Loewen, Ralitsa, Shridhar, Viji, Cliby, and William A. Heterozygous ATR mutations in mismatch repair-deficient cancer cells have functional significance. Cancer Res. 65 (2005) 7091-7095
38. Menoyo A., Alazzouzi H., Espin E., Armengol M., Yamamoto H., and Schwartz Jr. S. Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microsatellite instability. Cancer Res. 61 (2001) 7727-7730
39. Viale A., De Franco F., Orleth A., Cambiaghi V., Giuliani V., Bossi D., Ronchini C., Ronzoni S., Muradore I., Monestiroli S., Gobbi A., Alcalay M., Minucci S., and Pelicci P.G. Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells. Nature 457 (2009) 51-56
40. Heffernan T.P., Kawasumi M., Blasina A., Anderes K., Conney A.H., and Nghiem P. ATR-Chk1 pathway inhibition promotes apoptosis after UV treatment in primary human keratinocytes: potential basis for the UV protective effects of caffeine. J. Invest. Dermatol. 129 7 (2009) 1611-1613
41. Kerzendorfer C., and O'Driscoll M. UVB and caffeine: inhibiting the DNA damage response to protect against the adverse effects of UVB. J. Invest. Dermatol. 129 (2009) 1611-1613
42. Lu Y.-P., Lou Y.-R., Xie J.-G., Peng Q.-Y., Liao J., Yang C.S., Huang M.-T., and Conney A.H. Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 12455-12460
43. Lu Y.-P., Lou Y.-R., Peng Q.-Y., Xie J.-G., Nghiem P., and Conney A.H. Effect of caffeine on the ATR/Chk1 pathway in the epidermis of UVB-irradiated mice. Cancer Res. 68 (2008) 2523-2529
44. Jonason A.S., Kunala S., Price G.J., Restifo R.J., Spinelli H.M., Persing J.A., Leffell D.J., Tarone R.E., and Brash D.E. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 14025-14029
45. Wang Q., Fan S., Eastman A., Worland P.J., Sausville E.A., and O'Connor P.M. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. J. Natl. Cancer Inst. 88 (1996) 956-965